Endogenous expression mapping of malignant melanoma by mass spectrometry imaging

Abstract Background Currently, only a limited number of molecular biomarkers for malignant melanoma exist. This is the case for both diagnosing the disease, staging, and efficiently measuring the response to therapy by tracing the progression of disease development and drug impact. There is a great...

Full description

Bibliographic Details
Main Authors: Yutaka Sugihara, Daniel Rivas, Johan Malm, Marcell Szasz, HoJeong Kwon, Bo Baldetorp, Håkan Olsson, Christian Ingvar, Melinda Rezeli, Thomas E. Fehniger, György Marko-Varga
Format: Article
Language:English
Published: Wiley 2018-08-01
Series:Clinical and Translational Medicine
Subjects:
Online Access:http://link.springer.com/article/10.1186/s40169-018-0201-x